A Long-term Extension Study of Ustekinumab in Pediatric Participants

Clinical trial NCT05092269 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05092269
Sponsor: Janssen Research & Development, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn Disease Colitis, Ulcerative Arthritis, Psoriatic

Start date: 2021-10-18
Primary completion: 2027-09-29
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.